Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 199

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Guillain-Barré syndrome following COVID-19: new infection, old complication?

Open access
Padroni, Marina, Mastrangelo, Vincenzo, Asioli, Gian Maria, Pavolucci, Lucia, Abu-Rumeileh, Samir, Piscaglia, Maria Grazia, Querzani, Pietro, Callegarini, Claudio, Foschi, Matteo · 2020 · Journal of Neurology

Abstract

The coronavirus disease-2019 (COVID-19) pandemic originated in Wuhan (China) on December 2019. So far, more than 1,500,000 cases have been confirmed worldwide (> 150,000 cases in Italy) [1]. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is a systemic disorder typically presenting with fever, fatigue and prevalent respiratory disturbances (dry cough, dyspnea, chest pain, interstitial pneumonia) [2], although neurological manifestations are increasingly reported [3]. Guillain-Barré syndrome (GBS) is an acute/subacute immune-mediated polyradiculoneuropathy characterized by varying degrees of limbs or cranial-nerves weakness, loss of deep tendon reflexes, sensory and dysautonomic symptoms due to peripheral nerves and roots demyelination and/or axonal damage [4]. According to a recent review about twothird of all GBS are preceded by upper respiratory infection or enteritis [4]. Here we describe a case of GBS following a clinically resolved paucisymptomatic COVID-19. A 70-year-old-woman was referred to our emergency department (ED) on Mar-28 complaining of asthenia, hands and feet paresthesia and gait difficulties progressing within 1 day. On Mar-4 she had developed fever (body temperature—BT = 38.5 °C) and dry cough. A day later she had been tested positive for SARS-CoV-2-RNA on RT-PCR with a nasopharyngeal swab. Symptoms of COVID-19 had resolved in a few days. The epidemiological survey had revealed a previous hospital visit to an inpatient in an area with high incidence for COVID-19 (Piacenza, Italy) on Feb28, 29. At the ED admission BT was 36.5 °C, oxygen saturation was 98% on room air. Arterial blood gas analysis showed pO2 = 76 mmHg with normal p/f ratio (= 363). Hematological investigations revealed slightly increased white blood cells (10.41 × 109/L, normal = 4–10 × 109/L) with 8.15 × 109/L neutrophils (normal = 2–8 × 109/L) and lymphocytes in the normal range. D-dimer, creatine phosphokinase, blood glucose, hepatic and renal function were normal, as well as c-reactive protein, erythrocyte sedimentation rate, folate and vitamin B12 blood levels. A chest high-resolution computed tomography revealed some small “ground glass” areas in both lungs. A repeated nasopharyngeal swab for SARS-CoV-2-RNA was negative. Mycoplasma Pneumoniae and Cytomegalovirus (CMV) serology (IgM and IgG), Legionella Pneumophila and Streptococcus Pneumoniae urinary tests were unrevealing. The neurological examination disclosed moderate (Medical Research Council grade 4/5) symmetric distal upper and lower limbs weakness, loss of deep tendon reflexes, preserved light touch and pinprick sensation. On Mar-31 a lumbar puncture was performed. The cerebrospinal fluid (CSF) analysis revealed slight albumino-cytological dissociation (CSF proteins = 48 mg/dL, normal = 0–40 mg/dL, white blood cells = 1 × 106/L, normal = 0–8 × 106/L). Microbiologic testing on CSF was negative (including herpes simplex virus, varicella zoster virus, Epstein-Bar virus, CMV, HIV-1, Borrelia Burgdorferi IgM and IgG). Neurophysiologic findings were consistent with a diagnosis of GBS (Table 1), according to current criteria [5]. A trial with 400 mg/die intravenous immunoglobulin (IVIg) for 5 days was started. On Apr-1 the patient was intubated and mechanical ventilation was applied, because of respiratory failure due to the worsening of muscle weakness. * Matteo Foschi mattfos89@gmail.com

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00415-020-09849-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 199

Metadata

Authors
Padroni, M., Mastrangelo, V., Asioli, G. M., Pavolucci, L., Abu-Rumeileh, S., Piscaglia, M. G., Querzani, P., Callegarini, C., & Foschi, M.
Venue
Journal of Neurology
Published
2020-04-24
Volume
267
Issue
7
Pages
1877-1879
ISSN
  • 0012-1037 (ISSN-L)
  • 0340-5354
  • 1432-1459
OpenAlex
W3019396830
Cited by
199
References
2
FWCI
17.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guillain-Barré syndrome following COVID-19: new infection, old complication? https://app.cochat.ai/papers/10.1007/s00415-020-09849-6
The paper
Padroni, M., Mastrangelo, V., Asioli, G. M., Pavolucci, L., Abu-Rumeileh, S., Piscaglia, M. G., Querzani, P., Callegarini, C., & Foschi, M. (2020). Guillain-Barré syndrome following COVID-19: new infection, old complication? Journal of Neurology. https://doi.org/10.1007/s00415-020-09849-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.